StocksDeepDive
Snapshot · TOPIX 500 · generated 2026-11-11 21:48 UTC

4527.T — Rohto Pharmaceutical Co.,Ltd.

UNDERVALUED (MOS +46.1%) · Quality 55/100

Value Score 30 days ago: 40.7 → today 42.1

Price
2629
Intrinsic value
4880.19
Margin of safety
+46.1%
Implied growth (reverse DCF)
+6.6%
model assumes +16.2%
Value Score
42.1
Quality
55
Psychology
14.6
Discovery
17.8
price/volume attention only
Moat score
37.2
erosion: none

Value Score: top 30% of TOPIX 500 · Quality: bottom 34%

Dividend: 50/share (TTM) · yield 1.9% · payout 34%

Open the interactive Deep Dive for 4527.T →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/4527.T - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is 4527.T undervalued?

As of 2026-11-11, 4527.T trades at 2629 against a computed intrinsic value of 4880.19 (+46.1% margin of safety) - StocksDeepDive's valuation label for this is UNDERVALUED. This is a described calculation from public data, not a recommendation.

What is Rohto Pharmaceutical Co.,Ltd.'s Value Score?

Rohto Pharmaceutical Co.,Ltd.'s Value Score is 42.1 as of 2026-11-11 - it combines value, quality, crowd psychology and market attention into one number.

Does 4527.T pay a dividend?

Yes - 4527.T's trailing twelve-month dividend is 50/share, a yield of 1.9% at the current price (as of 2026-11-11).